13.12
Schlusskurs vom Vortag:
$12.75
Offen:
$13.06
24-Stunden-Volumen:
218.10K
Relative Volume:
0.95
Marktkapitalisierung:
$143.98M
Einnahmen:
$1.07B
Nettoeinkommen (Verlust:
$99.41M
KGV:
1.4481
EPS:
9.06
Netto-Cashflow:
$141.17M
1W Leistung:
+0.15%
1M Leistung:
+3.23%
6M Leistung:
-32.41%
1J Leistung:
-47.50%
Medifast Inc Stock (MED) Company Profile
Firmenname
Medifast Inc
Sektor
Branche
Telefon
(732) 764-0619
Adresse
11445 CRONHILL DRIVE, OWINGS MILLS, MD
Vergleichen Sie MED mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
MED
Medifast Inc
|
13.12 | 143.98M | 1.07B | 99.41M | 141.17M | 9.06 |
![]()
ROL
Rollins Inc
|
55.73 | 27.62B | 3.46B | 477.23M | 599.93M | 0.99 |
![]()
SCI
Service Corp International
|
76.56 | 10.70B | 4.15B | 505.69M | 587.50M | 3.44 |
![]()
HRB
H R Block Inc
|
57.50 | 8.23B | 3.62B | 586.22M | 657.77M | 4.10 |
![]()
BFAM
Bright Horizons Family Solutions Inc
|
122.96 | 7.28B | 2.63B | 116.59M | 215.93M | 1.99 |
![]()
FTDR
Frontdoor Inc
|
54.74 | 3.85B | 1.83B | 234.00M | 235.00M | 3.03 |
Medifast Inc Stock (MED) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-11-05 | Hochstufung | DA Davidson | Underperform → Neutral |
2024-06-05 | Herabstufung | DA Davidson | Neutral → Underperform |
2023-10-13 | Eingeleitet | Stephens | Equal-Weight |
2022-11-04 | Herabstufung | DA Davidson | Buy → Neutral |
2022-08-04 | Herabstufung | Jefferies | Buy → Hold |
2021-01-25 | Hochstufung | Jefferies | Hold → Buy |
2020-11-05 | Hochstufung | DA Davidson | Neutral → Buy |
2020-06-25 | Eingeleitet | B. Riley FBR | Buy |
2020-02-27 | Herabstufung | Jefferies | Buy → Hold |
2019-11-08 | Herabstufung | Dougherty & Company | Buy → Neutral |
2019-07-25 | Eingeleitet | Jefferies | Buy |
2018-11-08 | Hochstufung | Sidoti | Neutral → Buy |
2018-03-07 | Hochstufung | Sidoti | Neutral → Buy |
2017-09-15 | Bestätigt | DA Davidson | Buy |
2016-08-04 | Bestätigt | Wunderlich | Hold |
2016-01-11 | Hochstufung | Sidoti | Neutral → Buy |
2015-11-30 | Herabstufung | Sidoti | Buy → Neutral |
2015-10-05 | Hochstufung | Sidoti | Neutral → Buy |
2014-11-07 | Herabstufung | Imperial Capital | Outperform → In-line |
2014-08-08 | Bestätigt | Imperial Capital | Outperform |
2014-04-23 | Bestätigt | Imperial Capital | Outperform |
2013-09-06 | Eingeleitet | Imperial Capital | Outperform |
2012-11-06 | Bestätigt | Northland Securities | Outperform |
2012-07-27 | Hochstufung | Northland Securities | Market Perform → Outperform |
2012-07-09 | Herabstufung | Standpoint Research | Buy → Hold |
2012-01-30 | Eingeleitet | Standpoint Research | Buy |
Alle ansehen
Medifast Inc Aktie (MED) Neueste Nachrichten
MED Q1 Earnings Call: Revenue Misses, Coach Productivity and GLP-1 Strategy in Focus - Yahoo Finance
Medifast projects Q2 2025 revenue of $85M-$105M amid coach strategy enhancements - MSN
Earnings Release: Here's Why Analysts Cut Their Medifast, Inc. (NYSE:MED) Price Target To US$15.00 - Yahoo Finance
Medifast, Inc. (NYSE:MED) Just Reported, And Analysts Assigned A US$15.00 Price Target - simplywall.st
Medifast stock hits 52-week low at $14.88 amid sharp decline - MSN
Medifast Q1 Loss Wider Than Expected, Sales Down 33.8% Y/Y - MSN
Medifast’s Earnings Call: Mixed Sentiment Amid Challenges - TipRanks
Earnings call transcript: Medifast Q1 2025 sees smaller-than-expected loss - Investing.com Australia
Form DEF 14A MEDIFAST INC For: Jun 18 - StreetInsider
Press Release Distribution & PR Platform - ACCESS Newswire
Medifast, Inc. (NYSE:MED) Q1 2025 Earnings Call Transcript - MSN
Medifast Q1 2025 slides: Adapting strategy for GLP-1 era amid revenue challenges - Investing.com Australia
Medifast shares drop as revenue misses estimates, guidance disappoints By Investing.com - Investing.com India
Medifast Inc (MED) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Focus By GuruFocus - Investing.com Canada
Medifast: Q1 Earnings Snapshot - The Washington Post
Medifast Inc Q1 2025 Earnings: EPS of -$0.07 Beats Estimates, Re - GuruFocus
MED Revenue Decline Highlights Challenges in Health and Wellness Sector | MED Stock News - GuruFocus
Medifast, Inc. 2025 Q1ResultsEarnings Call Presentation (NYSE:MED) - Seeking Alpha
Medifast (NYSE:MED) Misses Q1 Sales Targets - Yahoo Finance
Medifast shares drop as revenue misses estimates, guidance disappoints - Investing.com Australia
Medifast Announces First Quarter 2025 Financial Results - Business Wire
Geode Capital Management LLC Purchases 1,447 Shares of Medifast, Inc. (NYSE:MED) - Defense World
Earnings To Watch: Medifast (MED) Reports Q1 Results Tomorrow - Yahoo Finance
Medifast, Inc. (NYSE:MED) Stock Holdings Lessened by Russell Investments Group Ltd. - Defense World
Medifast Inc expected to post a loss of 27 cents a shareEarnings Preview - TradingView
Uncovering Potential: Medifast's Earnings Preview - Benzinga
Medifast to Report Q1 Earnings: What Investors Should Expect - MSN
Medifast Trades Near 52-Week Low: What's the Best Move Now? - MSN
Medifast stock hits 52-week low at $12.27 amid sharp decline By Investing.com - Investing.com South Africa
Medifast stock hits 52-week low at $12.27 amid sharp decline - Investing.com Australia
Medifast Q1 2025 Earnings Coming April 28: CEO to Detail OPTAVIA Performance - Stock Titan
Arrowstreet Capital Limited Partnership Sells 180,332 Shares of Medifast, Inc. (NYSE:MED) - Defense World
Medifast, Inc. (NYSE:MED) Q4 2024 Earnings Call Transcript - MSN
Personal Care Stocks Q4 Results: Benchmarking Medifast (NYSE:MED) - The Globe and Mail
Finanzdaten der Medifast Inc-Aktie (MED)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):